Advertisement
UK markets open in 25 minutes
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,734.07
    +449.53 (+2.60%)
     
  • CRUDE OIL

    83.99
    +0.42 (+0.50%)
     
  • GOLD FUTURES

    2,351.40
    +8.90 (+0.38%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • Bitcoin GBP

    51,516.22
    +83.50 (+0.16%)
     
  • CMC Crypto 200

    1,391.58
    -4.95 (-0.35%)
     
  • NASDAQ Composite

    15,611.76
    -100.99 (-0.64%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

$21 Billion Shows Two Bond Markets Aren't Equal

$21 Billion Shows Two Bond Markets Aren't Equal

Bayer AG is finding it harder to sell debt in its home country than in the U.S., a telling sign of the respective health of the euro and dollar credit markets. The German chemical giant wanted to complete the financing for its $63 billion acquisition of Monsanto Co. — but it had to pay up to do that in Europe. Once the new issue premium — the extra yield investors are offered to buy the new securities over existing ones of a comparable maturity — was reduced by the underwriters, the bonds were eventually priced close to where Bayer's existing bonds are trading.